International immunopharmacology

Improved immune response to shingles virus using β-sitosterol-modified lipid particles in mRNA vaccines

Updated

Abstract

High-level substitution of dendrogenin A (≥50%) impaired immune responses, while complete replacement with β-sitosterol enhanced T-cell responses.

  • The reactivation of varicella-zoster virus leads to herpes zoster, which is particularly burdensome for immunocompromised individuals.
  • Current herpes zoster vaccines have limitations, including age-dependent efficacy and manufacturing challenges.
  • mRNA vaccines could offer a new approach for preventing herpes zoster, relying on lipid nanoparticles (LNPs) for effective delivery.
  • Partial or complete replacement of cholesterol in LNPs with plant-derived β-sitosterol or dendrogenin A was tested.
  • Complete replacement with β-sitosterol resulted in higher antigen-specific T-cell responses compared to traditional cholesterol-based LNPs.
  • The immune response patterns induced by β-sitosterol-based LNPs were similar to those from cholesterol-based LNPs, lacking distinct inflammatory markers.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free